Primary Antibodies for Neuroscience

Atlas Antibodies is the original manufacturer of primary monoclonal and polyclonal antibodies targeting a broad spectrum of markers relevant to neuroscience research and tailored for use on human and rodent tissue samples.

Discover our markers for neuroinflammation, glioma, cortical layers, neural stem cells, and more.

Highly validated PrecisA Monoclonals and Triple A Polyclonals

Atlas Antibodies’ PrecisA Monoclonals and Triple A Polyclonals antibodies are validated for use in IHC, WB and ICC-IF. Enhanced validation is applied as an extra layer of antibodies validation thus ensuring high specificity and selectivity for the target proteins.


Explore full catalog

Highly validated PrecisA Monoclonals and Triple A Polyclonals

Atlas Antibodies in Neuroscience

Neuroscience Marker Panel

The nervous system controls and regulates involuntary and voluntary processes in the organism, including higher-order functions such as perception, cognition, emotions, and others.


At Atlas Antibodies, we have developed a panel of PrecisA Monoclonals primary antibodies designed to recognize the main anatomical and neurochemical cell types in rodents and the human nervous system.


Explore White Paper

Neuroscience Marker Panel

Neural Lineage Development Markers

Atlas Antibodies manufactures primary polyclonal and monoclonal antibodies targeting relevant markers in the neural lineage development pathways such as: E-cadherin/CDH1FABP7/BLBPEOMES/TBR2DCXRBFOX3/NeuN, and many more.

Explore NEW White Paper- Neural Lineage Markers >>> 

Download Infographic >>>

Explore Neural Lineage Development Markers

Neural Lineage Development Markers

Neuroinflammation Markers

Neuroinflammation broadly defines the collective reactive immune response in the brain and spinal cord in response to injury and disease.

Atlas Antibodies offers a wide range of neuroinflammation antibodies targeting non-neuronal cell types involved in neuroinflammation processes such as

Read Neuroinflammation White Paper

Explore Neuroinflammation Markers

Neuroinflammation Markers

Cortical Layer Markers

Cortical layer markers are useful tools for studying the development, functional neuroanatomy, and pathology of the cerebral cortex. The cerebral cortex is organized into six layers of both morphologically and functionally divergent neurons. The different layers can be identified using antibodies against the specific protein expressed in each layer.

Read Cortical Layer Markers White Paper

Explore Cortical Layer Markers

 Cortical Layer Markers

Glioma Markers

Atlas Antibodies offers antibodies targeting the glioma proteome, the tumor microenvironment and the key molecular markers for glioma classification.

Gliomas are one of the most aggressive and lethal solid tumors of the central nervous system. 

Read White Paper Glioma Markers

Explore Glioma Markers

Markers for Glioma Classification

ATRX has become a routine marker for the classification of gliomas and is most often used in combination with various other markers such as IDH1 and GFAP.

We also suggest related products.

Read White Paper ATRX Glioma Marker

Explore ATRX Marker 

Neural Stem Cell Markers

Stem cells have a capacity for self-renewal by producing more of the same cell type. Changes in the expression levels of specific molecules help identify the presence of neural stem cells in studies focused on further differentiation toward distinct neural lineages. Our neural stem cells offer a unique and powerful tool for basic research and regenerative medicine.

Read Neural Stem Cell Markers White Paper

Explore Embryonic and Somatic Stem Cell Markers

Neural Stem Cell Markers

The Brain Atlas

The brain is the most complex and fascinating organ of the human body. The Brain Atlas, a section of the Human Protein Atlas project, explores the spatial profiling and distribution of protein expression in the mammalian brain by integrating data from human, pig, and mouse brains.

Explore the Brain Atlas

The Glioma Proteome

Gliomas are tumors with an estimated origin from glial cells, accounting for approximately 80% of all malignant intracranial tumors. Gliomas are classified according to the cell type of origin, differentiation, and malignancy grade. The glioma proteome is built using TCGA transcriptomics and antibody-based protein data. 

Explore the Glioma Proteome

Neuroscience Blog Posts

Glioma classification and key molecular pathology

Learn about key molecular markers that allow the latest classification of gliomas.

Read Blog Post

Monoclonal antibody development for neuroscience research

Interview with Dr. Eugenia Kuteeva

Read Blog Post

See our neuroscience antibodies in action

Three recent studies showing our antibodies in neuroscience research.

Read Blog Post

Browse Primary Antibodies

Find the antibody you need in our product catalog.

Browse Products


Scientific Support

Need help finding the right product or advice on how to use our products? Find everything you need in our scientific support section. 

Go to Scientific Support

Customer Support

Do you need help on how to buy our products, or information about shipping and payments? Find the information you need in our customer support section.

Go to Customer Support